Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)

Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.

Automated summary

Hyper- and dyslipidemia significantly contribute to cardiovascular diseases and mortality in diabetic individuals. Extensive evidence supports the usage of lipid-lowering drugs to reduce cardiovascular risk in diabetic patients. This article outlines the recommendations of the Austrian Diabetes Association regarding the use of lipid-lowering drugs based on current scientific evidence.